Treatment of sleep-wake disorders

Details for Australian Patent Application No. 2006254899 (hide)

Owner SK Holdings Co., Ltd.

Inventors Drinkenburg, Wilhelmus; Sporn, Jonathan; Palumbo, Joseph; Ahnaou, Abdallah

Agent Griffith Hack

Pub. Number AU-B-2006254899

PCT Pub. Number WO2006/133393

Priority 60/688,638 08.06.05 US

Filing date 7 June 2006

Wipo publication date 14 December 2006

Acceptance publication date 24 November 2011

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133393 Priority application(s): WO2006/133393

6 March 2008 Alteration of Name

  The name of the applicant has been altered to SK Holdings Co., Ltd.

24 November 2011 Application Accepted

  Published as AU-B-2006254899

2 February 2012 Assignment before Grant

  SK Holdings Co., Ltd. The application has been assigned to SK Biopharmaceuticals Co., Ltd.

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254902-Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

2006254897-Improved treatment for anemia using a HIF-alpha stabilising agent